Table 2 Echocardiographic parameters and clinical outcomes for all patients and stratified by myocardial injury
All n = 152 | No myocardial injury n = 76 | Myocardial injury n = 76 | p | |
|---|---|---|---|---|
LVEF % (IQR), n = 127 | 50 (41–57) | 51 (45–58) | 48 (38–55) | 0.09 |
s´ cm/s (IQR), n = 80 | 8.3 (6.5–10.6) | 9.5 (7.3–11.4) | 8.0 (6.4–9.5) | 0.09 |
LVLS % (IQR), n = 107 | − 13.0 (− 16.4 to − 10.0) | − 14.2 (− 17.4 to − 10.8) | − 12.4 (-14.4 to − 9.3) | 0.02 |
MAPSE mm (IQR), n = 122 | 9 (8–12) | 11 (8–13) | 9 (6–10) | < 0.001 |
LV-LWFS % (IQR), n = 121 | 10.5 (8.6–12.6) | 11.6 (9.4–14.0) | 10.0 (7.4–11.7) | < 0.001 |
ICU-free days (IQR) | 21 (0–27) | 22 (6–27) | 18 (0–26) | 0.07 |
Vasopressors/inotropes-free days (IQR) | 26 (7–28) | 27 (16–28) | 24 (0–28) | 0.06 |
Mechanical ventilation-free days (IQR) | 23 (0–30) | 25 (8–30) | 22 (0–30) | 0.19 |
CRRT in ICU n (%) | 46 (31) | 18 (26) | 26 (35) | 0.24 |
CRRT-free days (IQR) | 30 (14–30) | 30 (20–30) | 27 (0–30) | 0.04 |
Organ support-free days (IQR) | 23 (0–28) | 24 (7–28) | 21 (0–28) | 0.13 |
ICU mortality n (%) | 28 (18) | 10 (14) | 16 (21) | 0.27 |
30-day mortality n (%) | 32 (21) | 12 (17) | 18 (24) | 0.31 |